EP0614364A4 - Procedes et compositions destines a traiter des infections a l'aide de (s)-lomefloxacine optiquement pure. - Google Patents

Procedes et compositions destines a traiter des infections a l'aide de (s)-lomefloxacine optiquement pure.

Info

Publication number
EP0614364A4
EP0614364A4 EP9292925403A EP92925403A EP0614364A4 EP 0614364 A4 EP0614364 A4 EP 0614364A4 EP 9292925403 A EP9292925403 A EP 9292925403A EP 92925403 A EP92925403 A EP 92925403A EP 0614364 A4 EP0614364 A4 EP 0614364A4
Authority
EP
European Patent Office
Prior art keywords
lomefloxacin
compositions
methods
optically pure
treating infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP9292925403A
Other languages
German (de)
English (en)
Other versions
EP0614364A1 (fr
Inventor
James W Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of EP0614364A1 publication Critical patent/EP0614364A1/fr
Publication of EP0614364A4 publication Critical patent/EP0614364A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP9292925403A 1991-11-27 1992-11-25 Procedes et compositions destines a traiter des infections a l'aide de (s)-lomefloxacine optiquement pure. Ceased EP0614364A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79924391A 1991-11-27 1991-11-27
US799243 1991-11-27
PCT/US1992/010142 WO1993010785A1 (fr) 1991-11-27 1992-11-25 Procedes et compositions destines a traiter des infections a l'aide de (s)-lomefloxacine optiquement pure

Publications (2)

Publication Number Publication Date
EP0614364A1 EP0614364A1 (fr) 1994-09-14
EP0614364A4 true EP0614364A4 (fr) 1994-10-19

Family

ID=25175406

Family Applications (1)

Application Number Title Priority Date Filing Date
EP9292925403A Ceased EP0614364A4 (fr) 1991-11-27 1992-11-25 Procedes et compositions destines a traiter des infections a l'aide de (s)-lomefloxacine optiquement pure.

Country Status (5)

Country Link
EP (1) EP0614364A4 (fr)
JP (1) JPH07503457A (fr)
AU (2) AU3147493A (fr)
CA (1) CA2124443A1 (fr)
WO (1) WO1993010785A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0140116A1 (fr) * 1983-09-19 1985-05-08 Hokuriku Pharmaceutical Co.,Ltd Dérivé de l'acide fluoro-6-dihydro-1,4-oxo-4-pipérazinyl-7 substitué quinoléinecarboxylique-3 et procédé pour sa préparation
JPS60190777A (ja) * 1984-03-12 1985-09-28 Hokuriku Seiyaku Co Ltd 光学活性な６，８−ジフルオロ−１，４−ジヒドロ−４−オキソ−７−置換ピペラジニルキノリン−３−カルボン酸誘導体
JPH01242582A (ja) * 1988-03-22 1989-09-27 Hokuriku Seiyaku Co Ltd キノロンカルボン酸化合物ｉ型結晶の製造法
JPH02115182A (ja) * 1988-10-21 1990-04-27 Yoshitomi Pharmaceut Ind Ltd 光学活性ピリドンカルボン酸化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS618538A (ja) * 1984-06-25 1986-01-16 Shimizu Constr Co Ltd 工場等における空調機構

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0140116A1 (fr) * 1983-09-19 1985-05-08 Hokuriku Pharmaceutical Co.,Ltd Dérivé de l'acide fluoro-6-dihydro-1,4-oxo-4-pipérazinyl-7 substitué quinoléinecarboxylique-3 et procédé pour sa préparation
US4528287A (en) * 1983-09-19 1985-07-09 Hokuriku Pharmaceutical Co., Ltd. 6-Fluoro-1, 4-dihydro-4-oxo-7-substituted piperazinylquinoline-3-carboxylic acids and the method for preparing the same
JPS60190777A (ja) * 1984-03-12 1985-09-28 Hokuriku Seiyaku Co Ltd 光学活性な６，８−ジフルオロ−１，４−ジヒドロ−４−オキソ−７−置換ピペラジニルキノリン−３−カルボン酸誘導体
JPH01242582A (ja) * 1988-03-22 1989-09-27 Hokuriku Seiyaku Co Ltd キノロンカルボン酸化合物ｉ型結晶の製造法
JPH02115182A (ja) * 1988-10-21 1990-04-27 Yoshitomi Pharmaceut Ind Ltd 光学活性ピリドンカルボン酸化合物

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 10, no. 43 (C - 329) 20 February 1986 (1986-02-20) *
PATENT ABSTRACTS OF JAPAN vol. 13, no. 579 (C - 668) 20 December 1989 (1989-12-20) *
PATENT ABSTRACTS OF JAPAN vol. 14, no. 322 (C - 0739) 10 July 1990 (1990-07-10) *
See also references of WO9310785A1 *
T. UNE ET AL.: "IN VITRO ACTIVITY OF DR-3355, AN OPTICALLY ACTIVE OFLOXACIN", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 32, no. 9, 1988, pages 1336 - 1340 *

Also Published As

Publication number Publication date
AU1515197A (en) 1997-05-22
AU3147493A (en) 1993-06-28
EP0614364A1 (fr) 1994-09-14
WO1993010785A1 (fr) 1993-06-10
JPH07503457A (ja) 1995-04-13
CA2124443A1 (fr) 1993-06-10

Similar Documents

Publication Publication Date Title
EP0604433A4 (fr) Composition et procede de traitement de maladies.
GB9208339D0 (en) Treatment composition
GB9127150D0 (en) Novel treatment
AU644245B2 (en) Hair treatment composition
EP0596962A4 (en) Therapeutic compositions and methods.
AU2649092A (en) Desulphurisation treatment
EP0700292A4 (fr) Procedes et compositions de traitement de troubles gastriques a l'aide de pantoprazole (+) optiquement pur
GB9024928D0 (en) Novel treatment
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
EP0614364A4 (fr) Procedes et compositions destines a traiter des infections a l'aide de (s)-lomefloxacine optiquement pure.
GB2261432B (en) Treatment plant
GB2256237B (en) Treatment plant
AU7998691A (en) Compositions for treating hiv-type 1 infection
AU2595692A (en) Hair treatment composition
PH31066A (en) Treatment composition.
GB9024925D0 (en) Novel treatment
GB9024926D0 (en) Novel treatment
GB9105560D0 (en) Novel treatment i
GB9004943D0 (en) Dental compositions,procedure and method
GB9010163D0 (en) Novel treatment i
GB9113039D0 (en) Novel treatment and compositions
GB9113038D0 (en) Novel treatment and compositions
EP0760660A4 (fr) Traitement de certains etats par (-)-liarozole optiquement pur
GB9006081D0 (en) Treatment system
GB9112564D0 (en) Novel treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940624

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19940829

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19980303

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/495 A, 7A 61P 31/04 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20020610